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Abstract 
BACKGROUND AND AIM: This study was conducted to evaluate salivary immunoglobulin A (IgA) level in thalassemic 
patients with periodontitis in comparison to thalassemic patients with healthy periodontium. 
METHODS: Seventy-five patients were included in this study and were divided into three groups, group A: 25 major 
thalassemic patients with mild to moderate periodontitis, group B: 25 thalassemic patients with healthy periodontium, 
and group C: 25 systemically healthy people with normal periodontium. To measure salivary IgA levels, stimulated 
saliva was collected and analyzed by enzyme-linked immunosorbent assay (ELISA). The data were analyzed by t-test, 
ANOVA, and chi-square. 
RESULTS: Salivary IgA was significantly different in major thalassemia patients with periodontitis (69 µm/ml) in 
comparison to major thalassemia patients with healthy periodontium (81 µm/ml) (P < 0.05). The highest level of 
salivary IgA was observed in the systemically healthy people with normal periodontium (88 µm/ml). 
CONCLUSION: The levels of salivary IgA were decreased in major thalassemia patients with periodontitis and healthy 
periodontium in comparison to systemically healthy people with normal periodontium. 
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halassemia is a congenital disorder 
in which protruded maxilla, severe 
malocclusion, open bite, flattened 
bridge of the nose, upper lip 
protrusion and glossitis have been observed 
in these patients.1,2 In thalassemic patients, T 
cell response is diminished and cellular 
immunity impairment is seen.3 So immune 
system of these patients cannot control 
infection well and preventive dentistry is 
necessary because of anemia, iron overload, 
and splenectomy. 
Although the prevalence and severity of 
periodontal diseases have been demonstrated 
in association with a number of systemic 
diseases,4,5 but little information exists on the 
relationship between periodontal disease and 
thalassemia and there are contradictory 
results in this area.6 
In addition to the effect of thalassemia on 
systemic immunity, local defence system is 
also affected. Therefore, no changes in 
salivary immunoglobulin levels in 
thalassemia patients with gingivitis is due to 
lack of response of B-lymphocytes to gingival 
inflammation. It was shown that burning 
sensation and dry mouth are the most 
frequent oral manifestation in thalassemia 
patients. One of the causes of local immune 








http://johoe.kmu.ac.ir,    5 October 
Arabsolghar et al. Titers of salivary IgA in thalassemic patients 
      206       J Oral Health Oral Epidemiol/ Autumn 2016; Vol. 5, No. 4        
immune function. So, local salivary immunity 
of thalassemia patients is not responsive well 
against the gingivitis.7 
To date, few studies evaluated the level of 
salivary immunoglobulin A (IgA) in 
thalassemia patients, and the most studies 
have focused on serum immunoglobulin 
levels,8-10 that are inconsistent with salivary 
immunoglobulins titer results.7 Since there is 
little information about the relationship 
between periodontal disease and thalassemia, 
and the results of studies are contradictory, 
we compared salivary IgA titer in 
thalassemic patients with mild to moderate 
periodontitis and thalassemic patients with 
normal periodontium. 
Methods 
In this descriptive study, a total of 75 patients 
aged 10-25 years old were enrolled in three 
groups, group A: 25 major thalassemia 
patients with mild to moderate periodontitis, 
group B: 25 thalassemic patients with healthy 
periodontium, and group C: 25 systemically 
healthy people with normal periodontium. 
The groups were matched in terms of gender 
and age. This study was approved by Ethics 
Committee of Kerman University of Medical 
Sciences, Iran, and the ethical code was 
k/92/479. Exclusion criteria was any 
antibiotic use during the last 2 weeks. Before 
examination, the information of patients such 
as age, gender, and splenectomy was 
recorded. Diagnosis of periodontitis was 
based on clinical attachment level. To 
measure the clinical attachment level, a 
Williams probe was used to determine the 
distance between the cemento enamel 
junction (CEJ) and the base of pocket. In 
group A, amount of loss of attachment was 
between 1-4 mm while there was not any loss 
of attachment in groups B and C. Selection of 
patients was performed by an experienced 
periodontist. The patients were selected by 
convenience sampling.  
Collection of saliva sample 
Sampling of saliva was performed at the 
same time between 11 to 12 am in all patients. 
A few drops of 1% solution of citric acid was 
poured on the back of patient's tongue to 
stimulate salivary secretion and after  
1 minute, saliva was collected in sterilized tube 
and was sent to the laboratory in ice pack. 
Enzyme-linked immunosorbent assay 
(ELISA) protocol 
In this experiment, specific kit to measure 
salivary IgA (SigA, Salimertics, UK) has been 
used. When performing the test, the saliva 
samples which were frozen at -70 oC were 
first melted and after vortex they were 
centrifuged at 1500 g for 15 minutes in order 
to remove any mucins and other insoluble 
particles. Simultaneously, along with 
preparing the saliva samples, serial dilution 
(with the concentrations of 600, 200, 66.7, 
22.2, 7.4 , and 2.5 mg/ml) of the standard 
solution was made by using standard 
solution available in the kit. Next, by use of 
the diluent of the kit, the saliva samples were 
diluted to a ratio of 1:5 and then 50 ul of anti-
SIgA antibody which been conjugated with 
horseradish peroxidase (HRP) enzyme were 
added to the tubes containing the standard 
solutions and aslo the saliva. Accordingly, in 
such condition, the amount of extra antibody 
which was not attached to SIgA was 
conversely proportional to the amount of 
SIgA that was available in the samples. After 
90 minutes incubation in room temberature 
and mixing, 50 µl of the material inside the 
tubes were duplicated within the ELISA well 
plates whose surfaces were coated with 
human SIgA. All of the free conjugated anti-
SIgA antibodies were connected to the SIgA 
on the surface of ELISA wells. After 90 
minutes of incubation and six times washing 
with washing buffer, conjugated antibody 
attached to the SIgA on the surface was 
measured after adding 50 µl substrate 
3,3′,5,5′-Tetramethylbenzidine (TMB), 45 min 
incubation in darkness and adding Stop 
solution (1 normal sulfuric acid). The 
absorbance rate in each of the wells was 
measured by ELISA reader machine (Biotech, 
USA) at a wavelength of 450 nm. Using the 
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IgA dissolved in saliva in each of the samples 
was determined. Chi-square, t-test, analysis 
of variance and post-hoc Tukey test were 
used for statistical analysis. 
Results 
The age of all patients entered in this study 
was in the range of 10-25 years. Forty-six 
percent of patients were male and 54% were 
female. There was no significant relationship 
between age and gender and level of salivary 
IgA. IgA titer in group A was 69 µm/ml and 
it was 81 µm/ml and 88 µm/ml in groups B 
and C, respectively. 
Salivary IgA level is demonstrated in  
table 1 which expressed as mean ± standard 
deviation (SD) in these three groups. The 
maximum level of salivary IgA was reported 
in group C, and the least titer was seen in 
group A. The difference between these three 
groups was statistically significant (P < 0.05). 
Prevalence of splenectomy was 12.5% in 
group A and 16.0% in group B. There was no 
statistically difference between splenectomy 
and level of IgA in these patients (P > 0.05). 
 
Table 1. Comparison of salivary immunoglobulin 
A (IgA) levels in groups A, B, and C 
Groups Mean ± SD (µm/ml)  P 
Group A 69 8.5 0.003 
Group B 81 6.8 
Group B 81 6.8 0.001 
Group C 88 5.9 
Group A 69 8.5 0.001 
Group C 88 5.9 
SD: Standard deviation 
Discussion 
In thalassemic patients both local and 
systemic immunity systems are affected. 
Until now, a few studies evaluated the level 
of salivary IgA in thalassemic patients and 
most of them focused on serum 
immunoglobulins.8-10 
In our study, there was significant 
difference between thalassemic patients with 
periodontitis in comparison with thalassemic 
ones with healthy periodontium. The level of 
IgA in group A was lower than the group B. 
Furthermore, IgA level was lower in 
thalassemic groups in comparison with 
systemically healthy patients. 
In Siamopoulou-Mavridou et al.7 study, 
the levels of stimulated salivary IgA in 
thalassemic patients with gingivitis was 
lower than healthy people. This result is 
simillar to our study that was performed on 
periodontitis patients. In Motaleb Nejad et al. 
study,11 the levels of salivary antibodies in 
thalassemic patients with gingivitis was 
evaluated and although mean antibody level in 
gingivitis group was higher than control group 
but this difference was not significant. They 
justified this slight increase of antibody by 
immune system dysfunction.11 Their results 
were inconsistent with the results of our study. 
Apart from the two above-mentioned 
study,7-11 other studies have focused on the 
level of serum immunoglobulin and their 
results have been contradictory, so that some 
of them showed decrease while in other 
studies increase or no change was reported. 
In Macdougall et al. study,12 humoral 
immune system of children with iron 
deficiency was evaluated and the results 
demonstrated that the average concentration 
of serum IgA was normal and comparable 
with healthy adults. In another study that 
humoral immune system of thalassemic 
patients was investigated by Ghaffari et al.,13 
none of humoral immunity markers such as 
IgG, IgM, IgE was significantly different 
compared to healthy controls but there was a 
modest rise in antibody levels of IgA. They 
concluded that there was no need to evaluate 
humoral immune system in routine immune 
tests in thalassemic patients. In another 
study, serum levels of IgM and IgG were 
significantly higher in these patients and with 
increasing age, the amount of these 
antibodies increased.14 
In our study, IgA level was lower in 
thalassemic patients with periodontitis in 
comparison with thalassemic patients with 
healthy periodontium and both had lower 
values than systemically healthy people with 
normal periodontium. These differences 
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factors that affect the level of antibodies in 
saliva such as methodological problems and 
standardization of preparation, collection and 
storage of saliva, loss of protein during 
sample preparation and technical methods 
such as particle-enhanced nephelometric 
immunoassay and ELISA, flow rate of saliva, 
acute or chronic stress factors, age, gender, 
and geographic variables.15 
In the studies that collected the 
unstimulated saliva, amounts of IgA were at 
least 3 times more than studies in which the 
stimulated saliva was used. Stimulated saliva 
sampling is preferred, because the method is 
easier and not affected by saliva storage in 
salivary glands. Salivary IgA is a part of 
adoptive immune system. Therefore, daily 
and seasonal variations, type of food, 
smoking, level and type of male and female 
hormones can influence on IgA levels in 
different times.15-18 In thalassemic patients 
that undergo splenectomy surgery, systemic 
as well as local immune response is reduced, 
so that in studies on these patients gingival 
inflammation was higher than thalassemic 
patients with no history of this surgery.19 
Tovo et al.8 demonstrated that in the 
splenectomized patients in comparison to the 
non-splenectomized ones, a significant 
increase was observed in IgG and IgA in the 
elder ones while a significant reduction was 
observed in IgM. Because of the low sample 
size of our study for patients underwent 
splenectomy, the data did not show any 
association between splenectomy and  
IgA level.  
Our results showed that saliva of 
thalassemic patients cannot response well 
against infection because in these patients, 
function of T-cells is impaired and B-cells 
activity is influenced consequently and 
cannot defend well. 
Conclusion 
The results showed that salivary IgA in 
thalassemic patients with periodontist was 
lower than patients with normal 
periodontium. Because of impaired local 
immune systems in thalassemic patients, 
dental preventive and therapeutic 
consideration would be necessary. 
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